Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 10 Apr 2024

Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM

in Cancer Immunity and Immunotherapy

Dongyun Rong
Yushen Su
Dechao Jia
Zhirui Zeng
Yan Yang
Dalong Wei
Honguan Lu
Yu Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387316

2,704 views
6 citations

Review

Published on 10 Apr 2024

The interplay between autophagy and cGAS-STING signaling and its implications for cancer

in Cancer Immunity and Immunotherapy

Maximilian Schmid
Patrick Fischer
Magdalena Engl
Joachim Widder
Sylvia Kerschbaum-Gruber
Dea Slade

Frontiers in Immunology

doi 10.3389/fimmu.2024.1356369

9,552 views
9 citations

Review

Published on 10 Apr 2024

Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis

in Cancer Immunity and Immunotherapy

Jing Wang
Ziyue Guo
Mengyi Shen
Qi Xie
Hongjie Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366489

3,055 views
2 citations

Review

Published on 10 Apr 2024

Defining tropism and activity of natural and engineered extracellular vesicles

in Cancer Immunity and Immunotherapy

Wooil Choi
Dong Jun Park
Brian P. Eliceiri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1363185

3,383 views
12 citations

Original Research

Published on 10 Apr 2024

A novel web-based dynamic prognostic nomogram for gastric signet ring cell carcinoma: a multicenter population-based study

in Cancer Immunity and Immunotherapy

Yujuan Jiang
Haitao Hu
Xinxin Shao
Weikun Li
Yiming Lu
Jianwei Liang
Yantao Tian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365834

2,348 views
4 citations

Original Research

Published on 10 Apr 2024

A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy

in Cancer Immunity and Immunotherapy

Mei Li
Jun Liao
Li Wang
Tianye Lv
Qianfu Sun
Yan Xu
Zhi Guo
Manman Quan
Hao Qin
Haoyang Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1303259

2,353 views
2 citations

Mini Review

Published on 10 Apr 2024

Overcoming the challenges encountered in CAR-T therapy: latest updates from the 2023 ASH annual conference

in Cancer Immunity and Immunotherapy

Tingting Zhang
Yicheng Zhang
Jia Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1389324

3,960 views
2 citations

Original Research

Published on 10 Apr 2024

KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity

in Cancer Immunity and Immunotherapy

Rui Fan
Fahui Liu
Qiming Gong
Donghua Liu
Shihang Tang
Dongyan Shen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1393801

2,872 views
2 citations

Original Research

Published on 10 Apr 2024

A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

in Cancer Immunity and Immunotherapy

Yoel Z. Betancor
Miriam Ferreiro-Pantín
Urbano Anido-Herranz
Mar Fuentes-Losada
Luis León-Mateos
Silvia Margarita García-Acuña
Vanessa Vaamonde-Rodríguez
Beatriz García-Pinel
Víctor Cebey-López
Rosa Villaverde-Viaño

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374728

2,658 views
3 citations

Review

Published on 10 Apr 2024

Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges

in Cancer Immunity and Immunotherapy

Sadique A. Javed
Asim Najmi
Waquar Ahsan
Khalid Zoghebi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383456

10,083 views
32 citations

Review

Published on 09 Apr 2024

Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics

in Cancer Immunity and Immunotherapy

Mayura R. Dhamdhere
Vladimir S. Spiegelman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385875

3,065 views
5 citations

Editorial

Published on 09 Apr 2024

Editorial: New insights into innate immune cell-based immunotherapies in cancer

in Cancer Immunity and Immunotherapy

Anne Caignard
Mary Poupot-Marsan
Virginie Lafont
Daniela Wesch
Chiara Porta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401665

2,153 views
1 citation

Review

Published on 09 Apr 2024

Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges

in Cancer Immunity and Immunotherapy

Yuchu Xiang
Xudong Liu
Yifan Wang
Dawei Zheng
Qiuxing Meng
Lingling Jiang
Sha Yang
Sijia Zhang
Xin Zhang
Yan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1366260

14,743 views
30 citations

Original Research

Published on 09 Apr 2024

SLC7A11 inhibits ferroptosis and downregulates PD-L1 levels in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Zhenyao Huang
Xia Chen
Yun Wang
Jiali Yuan
Jing Li
Wenlu Hang
Hao Meng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372215

3,586 views
5 citations

Original Research

Published on 08 Apr 2024

Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy

in Cancer Immunity and Immunotherapy

Xin Yang
Qiao Li
Tianyang Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1364507

2,542 views
5 citations

Review

Published on 08 Apr 2024

Ferroptosis in liver cancer: a key role of post-translational modifications

in Cancer Immunity and Immunotherapy

Ying Xu
Zhiyao Xing
Ruaa Abdalla Ibrahim Suliman
Zichuan Liu
Fengyuan Tang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1375589

5,138 views
8 citations